Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of MXN 23.37 billion. The enterprise value is 30.84 billion.

Market Cap	23.37B
Enterprise Value	30.84B

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	175.43M
Shares Outstanding	n/a
Shares Change (YoY)	+3.85%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	164.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.45
PB Ratio	0.80
P/TBV Ratio	n/a
P/FCF Ratio	3.97
P/OCF Ratio	3.80
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.65, with an EV/FCF ratio of 5.23.

EV / Earnings	-1.49
EV / Sales	0.64
EV / EBITDA	35.65
EV / EBIT	n/a
EV / FCF	5.23

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 1.11.

Current Ratio	1.68
Quick Ratio	1.51
Debt / Equity	1.11
Debt / EBITDA	34.85
Debt / FCF	5.50
Interest Coverage	-7.80

Financial Efficiency

Return on equity (ROE) is -54.49% and return on invested capital (ROIC) is -3.38%.

Return on Equity (ROE)	-54.49%
Return on Assets (ROA)	-3.00%
Return on Invested Capital (ROIC)	-3.38%
Return on Capital Employed (ROCE)	-7.49%
Revenue Per Employee	10.31M
Profits Per Employee	-4.09M
Employee Count	5,500
Asset Turnover	0.66
Inventory Turnover	21.44

Taxes

Income Tax	-272.92M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.69%
50-Day Moving Average	138.64
200-Day Moving Average	180.14
Relative Strength Index (RSI)	66.37
Average Volume (20 Days)	93

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.62

Income Statement

In the last 12 months, Teladoc Health had revenue of MXN 52.18 billion and -20.69 billion in losses. Loss per share was -120.18.

Revenue	52.18B
Gross Profit	36.77B
Operating Income	-3.81B
Pretax Income	-20.96B
Net Income	-20.69B
EBITDA	670.83M
EBIT	-3.81B
Loss Per Share	-120.18

Full Income Statement

Balance Sheet

The company has 24.39 billion in cash and 32.43 billion in debt, giving a net cash position of -8.04 billion.

Cash & Cash Equivalents	24.39B
Total Debt	32.43B
Net Cash	-8.04B
Net Cash Per Share	n/a
Equity (Book Value)	29.17B
Book Value Per Share	166.34
Working Capital	13.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.15 billion and capital expenditures -252.77 million, giving a free cash flow of 5.89 billion.

Operating Cash Flow	6.15B
Capital Expenditures	-252.77M
Free Cash Flow	5.89B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.48%, with operating and profit margins of -7.31% and -39.66%.

Gross Margin	70.48%
Operating Margin	-7.31%
Pretax Margin	-40.18%
Profit Margin	-39.66%
EBITDA Margin	1.29%
EBIT Margin	-7.31%
FCF Margin	11.29%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.85%
Shareholder Yield	n/a
Earnings Yield	-88.55%
FCF Yield	25.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -5.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.33
Piotroski F-Score	4